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Patients undergoing hemodialysis for end-stage
renal disease (ESRD) require constant attention to
maintain vascular access. Failed access is the most fre-
quent cause of hospitalization for these patients, and
it necessitates expensive interventions to restore
function.1 Although mature, autologous arteriove-
nous fistulas (AVFs) have the best patency rates and
the least complications of the various access tech-
niques, many patients are not candidates for an AVF.1
Polytetrafluoroethylene (PTFE) arteriovenous grafts
(AVGs) are currently constructed almost twice as
often as autologous fistulas1 despite a discouraging
mean patency of only 13 months.2 Any means to
improve AVG patency and decrease the frequency of
revisions would improve the quality of life of patients
with ESRD and decrease health care expenditures.
Venous anastomosis intimal hyperplasia is the
most common cause of late AVG thrombosis1 and a
common cause of PTFE graft failure in infrainguinal
reconstructions. Compliance mismatch between a
rigid PTFE graft and a pliable outflow vessel has
been blamed for this hyperplasia. Vein collars and
patches have been used to decrease compliance mis-
match at the distal anastomoses of lower extremity
PTFE bypass grafts with improved patency report-
ed.3,4 The goal of this study was to determine if a
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Purpose: Vein collars and patches are used at the distal anastomoses of infrainguinal pros-
thetic grafts to improve graft patency. We initiated a randomized, prospective study to
determine whether a Tyrell vein collar at the venous anastomosis of forearm loop arte-
riovenous grafts (AVGs) would improve patency.
Methods: Patients who required new forearm AVGs were randomized to (1) a standard
end-to-side graft-vein anastomosis (control group) or (2) a Tyrell vein collar between
the graft and the vein (study group). End points were (1) graft thrombosis, (2) graft
removal and ligation, or (3) inadequate graft function. Randomization of 75 subjects was
planned. The study was terminated early for ethical reasons.
Results: Seventeen patients (eight men, nine women) with a mean age of 52.8 years
(range, 31-79 years) had 17 grafts placed (control group, n = 10; study group, n = 7).
Comorbidities were not different between the groups (P > .05). Six (86%) of seven study
grafts failed by 9 months (mean, 4.6 months). Four (66%) failed study grafts had venous
outflow tract stenosis from intimal hyperplasia. This was confirmed at surgery in three
and by angiography in one. The 9-month primary patency was 80% for the control group
versus 17% for the study group (P = .015). Smaller outflow vein diameter in the study
group (P = .048) did not account for this inferior graft patency.
Conclusion: A Tyrell vein collar at the venous anastomosis of a forearm AVG resulted in
premature graft failure. The use of a Tyrell vein collar may accelerate venous anastomo-
sis intimal hyperplasia. (J Vasc Surg 2000;32:1149-54.)
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Tyrell vein collar could improve primary AVG paten-
cy by decreasing compliance mismatch and venous
outflow tract intimal hyperplasia (Figure).
METHODS
From August 1996 to March 1998 (20 months),
all patients referred for hemodialysis access were con-
sidered for this study. The study was approved by the
Institutional Review Boards of the participating hos-
pitals. Patients were study candidates if they needed
new PTFE forearm loop grafts and gave informed
consent. Patients requiring AVG revision or an AVG
in the upper arm or leg were excluded. All data were
recorded on a standard reporting form. The preop-
erative history and physical examination of patients
focused on events and findings that might predispose
to early graft failure because of arterial insufficiency
or prior venous occlusive disease.
The patients were prospectively randomized to
have a conventional end-to-side venous anastomosis
(control group) or an end-to-side anastomosis with
a Tyrell vein collar between the graft and the out-
flow vein (study group). The vein used to create the
Tyrell collar in the study group was obtained from
either normal-appearing ipsilateral superficial fore-
arm veins (n = 5), or the greater saphenous vein or
its branches (n = 2). Three surgeons created 10 con-
trol AVGs (A, n = 6; B, n = 3; C, n = l), and two sur-
geons created the seven study AVGs (A, n = 6; D, n
= l). Details of the operative procedure were record-
ed (Table). Outflow vein diameter was measured
with a ruler after it was distended by the AVG.
Patients did not use their AVGs for 2 weeks after
surgery to allow for incorporation.
Postoperatively, the patients were examined for
complications and graft patency by the surgical staff at
regular intervals. Graft failure was defined as (1) graft
thrombosis, (2) graft removal and ligation, or (3)
inadequate graft function that required revision to
maintain patency and effective dialysis. Determination
of inadequate graft function was made by the staff of
the dialysis center. Graft thrombosis was confirmed by
the attending surgeon.
We planned on randomizing 75 patients for this
study to have a statistical power of 0.89 and a β value
of .11. When the study was terminated for ethical
consideration, the number of subjects in the study
and control groups was not equal because they were
not block randomized. Statistical analysis was per-
formed with the Student t test for continuous vari-
ables and the Fisher exact test for nominal variables.
RESULTS
Seventeen patients consented to participate in
this study. Subsequently, the recruitment of patients
was stopped for ethical concerns. Early graft failure
due to venous outflow obstruction was extremely
high in the first seven patients entered into the study
group. For this reason, we considered further ran-
domization in the study group to be inappropriate.
Nine women and eight men with a mean age of
52.8 years (median, 54 years; range, 31-79 years)
were randomized (control group, n = 10; study
group, n = 7). Patient demographics are compared
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Diagram of a Tyrell vein collar with and without a PTFE graft.
in the Table. Comorbidities were similar between
the two groups. No patients had abnormal or
unequal brachial blood pressures that required eval-
uation for arterial insufficiency. Three patients (one
from the control group, two from the study group)
had prior ipsilateral central venous lines. Central vein
stenosis was not evident by means of preoperative
venography or duplex scan examination in the two
patients studied. Six-millimeter regular PTFE grafts
were used in 16 (94%) of the 17 patients in the
study. One patient in the control group had a thin-
walled, 4- to 7-mm tapered PTFE graft (primary
patency, 14 months).
Comparison of the operative data for the control
and study groups identified outflow vein diameter
and total operative time as the only significantly dif-
ferent variables (Table). The increased operative time
in the study group reflected the extra time to form a
Tyrell vein collar. The outflow vein diameters were
statistically smaller (P = .048) in the study group (4.4
mm) than in the control group (5.2 mm). This dif-
ference was largely due to a patient in the study
group with a 3-mm outflow vein. The size of the out-
flow vein ranged from 4 to 6 mm for all other
patients in the study and control groups. There was
no statistical difference between the two groups if
this one 3-mm vein in the study group was excluded
from the analysis (mean diameter: control group, 5.2
mm; study group, 4.58 mm; P = .12). This patient
with a 3-mm outflow vein had a well-functioning
graft for 5 months before intimal hyperplasia in the
venous outflow tract led to graft thrombosis.
Six (86%) of the seven patients in the study
group had graft failure within 9 months of surgery.
A single study group AVG remains patent at 12
months, with no evidence revealed by duplex ultra-
sound scan of venous outflow stenosis. At 9 months,
only 20% of the grafts in the control group had
failed. The mean primary patency for the control
group was 13.4 months (range, 1-25 months) com-
pared with 4.6 months (range, 1-12 months) for the
study group. Primary patency at 9 months for the
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Comparison of perioperative comorbidities and technical data
Control group N(%) Study group N(%) P value
Preoperative data
Diabetes mellitus 3 (30) 2 (29) NS
Hypertension 10 (100) 7 (100) NS
CAD/CHF 2 (20) 3 (43) NS
Smoking 3 (30) 0 (0) NS
Prior ipsilateral AVF 2 (20) 2 (29) NS
Prior ipsilateral CIV 1 (10) 2 (29) NS
Operative data
Donor artery
Brachial 5 (50) 7 (100) NS
Radial 3 (30) 0 (0)
Ulnar 2 (20) 0 (0)
Outflow vein
Cephalic 2 (20) 1 (14) NS
Basilic 3 (30) 3 (43)
Median antecubital 3 (30) 1 (14)
Brachial 2 (20) 2 (29)
Vessel control
Clamp/vessel loop 7 (70) 6 (86) NS
Tourniquet 3 (30) 1 (14)
Graft across AC fossa 1 (10) 2 (29) NS
Mean (± SD) Mean (± SD)
Graft length (cm) 30.7 ± 3.5 33.4 ± 3.8 NS
Arteriotomy length (mm) 11.0 ± 2.7 13.3 ± 1.5 NS
Venotomy length (mm) 17.8 ± 5.8 15.4 ± 6.5 NS
Outflow vein diameter (mm) 5.2 ± 0.6 4.4 ± 0.9 .048
Operative time (min) 173 ± 56 213 ± 65 NS
Demographics: control group (n = 10) and study group (n = 7). The male-female ratio for control group is 5 (50%):5 (50%); for study
group, 3 (43%):4 (57%). Mean age of control group patients is 52.2 years (range, 31-79 years). Mean age of study group is 53.6 years
(range, 37-70 years).  
AC, Antecubital; AVF, arteriovenous fistula; CAD, coronary artery disease; CHF, congestive heart failure; CIV, central venous catheter;
NS, not significant.
grafts with a Tyrell vein collar (study group, n = 7)
was significantly inferior to that of the control group
(n = 10) (P = .015). The two AVGs with vein collars
from the greater saphenous vein or a large saphe-
nous branch vein failed at 1 and 2 months. Although
the small number (n = 7) of patients with vein col-
lars in the study group limited any statistical com-
parison, AVGs with arm vein collars appeared to
remain patent longer (mean, 5.6 months; range, 1-
12 months). If the one graft with the 3-mm outflow
vein was excluded from the statistical analysis, the
primary patency of the remaining study group AVGs
(n = 6) remained inferior (P = .035) to the control
group AVGs (n = 10).
A month after surgery, one patient in the study
group had graft failure subsequent to a prolonged
period of postdialysis hypotension. Her graft was sal-
vaged with thrombolysis, and angiography revealed
no stenosis in the graft or outflow tract. This graft
has functioned without further problems for a total
of 9 months (secondary patency). A second patient
in the study group had a steal syndrome 2 weeks
after her AVG was placed. Because of worsening
hand ischemia, the graft had to be ligated 1 month
after it was placed. Physical examination, segmental
pressures, and pulse volume recordings revealed no
proximal arterial occlusive disease.
We evaluated four thrombosed study group
AVGs with post-thrombolysis angiography (n = l) or
surgical exploration (n = 3). These grafts, which
failed 1.25, 2, 5, and 9 months after surgery, had
findings consistent with intimal hyperplasia at the
venous anastomosis. Angiography showed a smooth
tapered stenosis in the toe of the venous anastomo-
sis involving the first 1 to 2 cm of the venous out-
flow tract. Surgery identified a smooth, shiny,
stenotic intraluminal lesion at the toe of the venous
anastomosis and on the back wall of the outflow
vein. Of the six AVGs with Tyrell vein collars that
failed, four (66%) had venous stenoses from intimal
hyperplasia, one was ligated for arterial steal, and
one failed from hypotension without a stenosis.
Overall, four (57%) of seven patients in the study
group had graft thrombosis within 9 months of
surgery because of anastomotic intimal hyperplasia.
DISCUSSION
Almost a quarter of a million Americans undergo
dialysis each year for ESRD.1 Most require long-
term hemodialysis, and one third of these patients
receive inadequate dialysis, which may decrease their
survival.5 Failed vascular access contributes to the
problem of inadequate hemodialysis,5 and it also
accounts for the greatest number of days spent in the
hospital by these patients.1 Reliable, well-function-
ing vascular access is essential for improving the
quality and length of life for patients with ESRD.
Autologous AVFs are the vascular access of choice
for patients undergoing hemodialysis.1 They are asso-
ciated with a low risk of infection, and when mature,
they are extremely durable. Unfortunately, many
patients lack adequate autologous conduits for an
AVF, or they have an AVF that is inadequate for effec-
tive hemodialysis. As a result, the use of PTFE AVGs
for hemodialysis access is increasing.1 Unfortunately,
the mean primary patency of PTFE AVGs is reported
to be only 13 months and may be decreasing.1,2
The most common cause of late failure (> 1
month) of a well-functioning PTFE AVG is venous
outflow tract stenosis due to intimal hyperplasia.
Circulating factors, hemodynamic stresses, and com-
pliance mismatch have all been described as causing
venous anastomosis intimal hyperplasia.6 Compliance
mismatch describes the differences in the deforma-
tion properties of prosthetic grafts and native vessels.
These differences create a region of stress at anasto-
moses that increases graft thrombosis.7 Tyrell et al8
have noted that PTFE anastomosed to small arteries
also causes anastomotic distortion. Clark et al9 have
postulated that chronic compliance mismatch and
anastomotic distortion lead to chronic irritation of
the native vessel, intimal hyperplasia, and early PTFE
graft failure.
Intimal hyperplasia at the distal anastomosis of
infragenicular PTFE grafts results in premature graft
failure and poor primary patency rates.10-13 To
counter this, several authors have interposed a vein
collar or patch between PTFE bypass grafts and
infragenicular arteries.3,4,14 Theoretically, a vein col-
lar or a patch decrease anastomotic intimal hyperpla-
sia by (1) decreasing the chronic injury caused by
PTFE–native vessel compliance mismatch8; and (2)
shifting intimal hyperplasia from the native outflow
vessel to the vein collar or patch, thereby limiting its
hemodynamic impact.4 In a multicenter, random-
ized trial, Stonebridge et al15 showed improved
patency (50% vs 19% at 2 years) using a Miller vein
collar at the distal anastomosis of infragenicular
PTFE bypass grafts. A Taylor vein patch has also
yielded improved patency (58%4 and 81%16 at 3
years) when used at the distal anastomosis of infra-
genicular PTFE bypass grafts.
In this study, our hypothesis was that a venous
anastomosis Tyrell vein collar would improve AVG
patency for the same reasons it improves infragenic-
ular PTFE bypass graft patency. We expected that
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decreased compliance mismatch and anastomotic
distortion at the venous anastomosis would incite
less intimal hyperplasia and venous outflow tract
stenosis. We are experienced with the Tyrell collar
and chose to use this technique rather than other
published configurations for a variety of theoretical
and technical reasons (Figure).17,18 The Tyrell collar
may be easier to construct than a Linton patch in
small vessels, it has a more favorable angle to the
native vessel than a Miller cuff, and the vein is inter-
posed between the graft and native vessel along the
entire circumference of the anastomosis, unlike with
the Taylor patch.3,4,16-18
In contrast to our expectations, this study
showed that the use of a venous anastomosis Tyrell
vein collar actually diminished AVG patency. The
Tyrell collar appeared to accelerate graft failure by
promoting intimal hyperplasia in the venous outflow
tract. Although the number of patients in the study
was small, the marked difference in patency rates
between the AVGs in the control and study groups
and the recurrent finding of significant venous inti-
mal hyperplasia in the failed study group grafts led
us to accept these findings as clinically meaningful,
rather than as statistical chance. For this reason, we
decided that randomizing more patients to the study
arm of this trial was unethical.
Similar results have recently been reported by
Pipinos et al.19 In a prospective, randomized trial,
they found that although a Taylor patch at the
venous anastomosis of an AVG improved early (1
month) patency, at 6 months the grafts with a Taylor
patch had patency rates significantly inferior to con-
ventional AVGs (25% vs 47%). Interestingly, intimal
hyperplasia in the venous outflow tract was a promi-
nent cause of AVG failure in their vein patch group
as well. Unexpectedly, vein collar and patch adjuncts
at the venous anastomoses of AVGs seem to predis-
pose to intimal hyperplasia rather than prevent it.
From our study, it is not possible to explain why
a vein collar at the distal anastomosis of an arterial
bypass graft promotes graft patency, whereas a vein
collar at the venous anastomosis of an AVG decreas-
es graft patency. Hofstra et al,20 using vessel-wall
Doppler scan tracking techniques, have shown that
PTFE-arterial anastomoses respond differently than
PTFE-vein anastomoses under arterial pressure.
They found that although venous anastomoses
increased their cross-sectional area and changed
their capacity during the cardiac cycle, arterial anas-
tomoses showed a decrease in cross-sectional area
and no capacity change. This increase in the area and
capacitance of venous anastomoses during the car-
diac cycle may cause flow disturbances and abnormal
wall shear stresses that stimulate intimal hyperpla-
sia.20 A vein collar at the venous anastomosis of an
AVG may compound hemodynamic stresses that
overcome any benefit derived from decreasing com-
pliance mismatch. This may explain, in part, why a
vein collar and patch at the venous end of an AVG
seemed to promote intimal hyperplasia.
In conclusion, we found that a Tyrell vein collar
placed at the venous anastomosis of AVGs failed to
improve primary graft patency when compared with
conventional graft-vein anastomoses. A Tyrell collar
at the venous anastomosis of an AVG appeared to
increase intimal hyperplasia, venous outflow tract
stenosis, and early AVG thrombosis. A vein collar at
the venous anastomosis of an AVG seems to pro-
mote a different perianastomotic response than a
vein collar at the distal anastomosis of an arterial
bypass graft. This suggests that the interactions of
prosthetic grafts with veins may be different than the
interactions of prosthetic grafts with arteries. This
may be an important consideration in future
attempts to improve primary AVG patency.
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